Horizon 2020
Obelis has been a successful participant in the Horizon 2020 Research Programme since 2014.
Horizon 2020 was the EU's largest-ever research and innovation initiative, with approximately €80 billion in financing available over seven years (2014 to 2020).
During Horizon 2020, Obelis helped new innovative projects focusing its expertise on health technologies, including medical devices (MD), pharmaceutical, cosmetics, and advanced therapy medicinal products (ATMP).
Obelis has served as a regulatory partner and has given our expertise to major initiatives such as:
Source: http://ec.europa.eu